Epi-Minder device tracks epilepsy seizures
Medical device developer Epi-Minder has successfully completed an $18 million Series A funding round. The company is commercialising its implanted Minder electroencephalography (EEG) monitoring device for those suffering from epilepsy. Existing shareholders Cochlear, the Bionics Institute, Melbourne’s St Vincent’s Hospital and the University of Melbourne took part in the capital raising. Bionics Institute researchers and…